Bronchodilator Effect of Inhaled Formoterol vs Salbutamol Over 12 Hours-Reference-Cited by-同舟云学术

Bronchodilator Effect of Inhaled Formoterol vs Salbutamol Over 12 Hours

Published:1990-03 Issue:3 Volume:97 Page:590-594
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Maesen Francis P.V,Smeets Joseph J.,Gubbelmans Hendrik L.L.,Zweers Petra G.M.A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference4 articles.

1. Kurzcharakteristik des neuen Beta2-sympathikomimetikums Formoterol;Burghele;Atemwegs-Lungenkrankh,1988

2. Bronchodilatierende Wirkung von Formoterol in drei unterschiedlichen Dosierungen per inhalationem;Geisler;Atemwegs-Lungenkrankh,1988

3. Ergebnisse einer Dosisfindungsstudie mit Formoterol als Dosier-Aerosol;Nolte;Atemwegs-Lungenkrankh,1988

4. Inhaled formoterol: a new beta2-adrenoceptor, compared to salbutamol in asthmatic patients: duration of effect and side effects;Loefdahl;Am Rev Hespir Dis,1988

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitation of Formoterol, Salbutamol, and Salbutamol-4′-O-Sulfate in Human Urine and Serum via UHPLC-MS/MS;Separations;2023-06-22

2. What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?;Respirology;2020-03-31

3. Spotlight on glycopyrronium/formoterol fumarate inhalation aerosol in the management of COPD: design, development, and place in therapy;International Journal of Chronic Obstructive Pulmonary Disease;2017-08

4. Regulative Role of Atomic Auto Correlated Electronegativities and Polarizabilities in β2 Potency of Ultralong Acting Agonists Identified in QSAR Studies;Current Bioinformatics;2015-11-13

5. The Safety of Long-Acting Beta-Agonists and the Development of Combination Therapies for Asthma and COPD;Advances in Combination Therapy for Asthma and COPD;2012-02-29